Fischer Medical Ventures Reports Highest Quarterly Revenue in Five Quarters
Fischer Medical Ventures, a smallcap chemicals company, has reported its financial results for the quarter ending June 2024. Despite a 'Sell' call from MarketsMojo, the company's score has improved from 0 to 4 in the last three months. The quarter also saw the highest Profit After Tax and revenue in the last five quarters, with a positive near-term trend.
Revenue - Quarterly: Highest at Rs 2.60 cr. in the last five quarters. Near term Revenue trend is positive.Fischer Medical Ventures, a smallcap company in the chemicals industry, has recently announced its financial results for the quarter ending June 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.
According to the financial report, Fischer Medical's performance for the quarter has been flat. However, there has been a significant improvement in the company's score, which has increased from 0 to 4 in the last three months.
Despite the flat performance, there are some positive aspects to note from the financials. Fischer Medical has recorded its highest Profit After Tax (PAT) in the last five quarters, standing at Rs 0.60 crore. The near-term trend for PAT is also positive. Similarly, the company's revenue for the quarter has also been the highest in the last five quarters, at Rs 2.60 crore. The near-term trend for revenue is also positive.
Fischer Medical Ventures continues to make strides in the chemicals industry, with its financials showing signs of improvement. Investors and stakeholders can keep a close eye on the company's progress in the coming quarters.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
